2.1 Participants and Study Protocol
This study is a cross-sectional study and has been approved by the ethics committee. This study was conducted 6 weeks after the first COVID-19 case was officially announced. The individuals who were planned to participate in the study were determined by a virtual snowball sampling method and invited to participate in the web survey online. Data acquisition was stopped when the targeted sample size was reached within 5 consecutive days. A questionnaire consisting of 7 sub-units was sent to the participants. Section 1 of the questionnaire included sociodemographic features, section 2 included questions on the presence of symptoms for any infectious disease, contact with COVID-19, treatment, quarantine history, section 3 included questions on compliance with the measures taken (these questions were inspired by the 14 rules determined by the official authorities in our country), section 4 included questions on the source from which information about COVID-19 was acquired; level of knowledge, belief in the information received, health services and measures sufficiency level, level of belief in life chances. Section 5 included questions on anxiety associated with possible health and sociological losses of the pandemic. The 6th section consisted of DASS-21 related questions and section 7 consists of questions related to IES-R. DASS and IESR were used in previous pandemic studies.8,9 Data for individuals 18 and older who agree to participate voluntarily are included. Data of individuals with a history of bipolar disorder and/or psychotic disorder were not evaluated during the analysis phase.